Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
Launched by SHANGHAI 6TH PEOPLE'S HOSPITAL · Dec 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving surgical techniques for patients undergoing robotic thyroid surgery, which is a minimally invasive method for treating thyroid conditions like cancer and nodules. The researchers are developing a new tool called the Robotic Thyroidectomy Assessment Score (RTAS) to measure how well surgeons perform these complex procedures. The goal is to ensure that surgeries are done safely and effectively, leading to better outcomes for patients.
To participate in this trial, patients should have a diagnosis of differentiated thyroid cancer (not larger than 4 cm) or benign thyroid nodules (not larger than 6 cm) and should have high expectations for cosmetic results after surgery. Importantly, participants should not have had previous neck surgeries or radiation treatment, and their condition should not suggest that the cancer has spread beyond the thyroid. Those who qualify will undergo robotic thyroid surgery and have their surgical performance evaluated using the new scoring tool. This study aims to refine surgical skills and improve the overall patient experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm
- • Clinical diagnosis of benign thyroid nodules with a maximum diameter not exceeding 6 cm
- • Participants with high cosmetic expectations
- • Participants underwent robotic thyroidectomy without open conversion
- Exclusion Criteria:
- • Participants with history of neck surgery or radiation
- • Participants with vocal fold fixation by preoperative fibrolaryngoscope
- • Participants with preoperative examination suggestive of distant invasion
- • Participants with fusion or fixed of lymph nodes in the neck
About Shanghai 6th People's Hospital
Shanghai 6th People's Hospital is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, striving to enhance patient outcomes and contribute to medical knowledge. With a dedicated team of experienced researchers and clinicians, Shanghai 6th People's Hospital emphasizes rigorous scientific methodology and ethical standards, ensuring that all trials are conducted with the utmost integrity and patient safety in mind. Through collaboration with various stakeholders, the hospital aims to bridge the gap between clinical research and real-world application, ultimately improving healthcare delivery both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Shanghai, Shanghai, China
Patients applied
Trial Officials
Ling Zhan, Doctor
Principal Investigator
Shanghai 6th People's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported